These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25791449)
1. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Jadav SS; Kaptein S; Timiri A; De Burghgraeve T; Badavath VN; Ganesan R; Sinha BN; Neyts J; Leyssen P; Jayaprakash V Bioorg Med Chem Lett; 2015 Apr; 25(8):1747-1752. PubMed ID: 25791449 [TBL] [Abstract][Full Text] [Related]
2. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473 [TBL] [Abstract][Full Text] [Related]
3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel dengue virus entry inhibitors via a structure-based approach. Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194 [TBL] [Abstract][Full Text] [Related]
6. Epitopes based drug design for dengue virus envelope protein: A computational approach. Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M; Singh SK Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins. Mayhoub AS; Khaliq M; Kuhn RJ; Cushman M J Med Chem; 2011 Mar; 54(6):1704-14. PubMed ID: 21355607 [TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Anasir MI; Ramanathan B; Poh CL Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528 [TBL] [Abstract][Full Text] [Related]
11. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143 [TBL] [Abstract][Full Text] [Related]
12. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics. Parikesit AA; Kinanty ; Tambunan US Pak J Biol Sci; 2013 Dec; 16(24):1836-48. PubMed ID: 24516999 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735 [TBL] [Abstract][Full Text] [Related]
14. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. de la Guardia C; Stephens DE; Dang HT; Quijada M; Larionov OV; Lleonart R Molecules; 2018 Mar; 23(3):. PubMed ID: 29547522 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel target sites and an inhibitor of the dengue virus E protein. Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406 [TBL] [Abstract][Full Text] [Related]
17. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243 [TBL] [Abstract][Full Text] [Related]
18. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads. Gangopadhyay A; Chakraborty HJ; Datta A J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821 [TBL] [Abstract][Full Text] [Related]
19. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S Virol J; 2015 Feb; 12():16. PubMed ID: 25886260 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents. Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]